Furthermore, we subjected primary AML cells to CRISPR-mediated targeting of the KDM5C and AAVS1 loci, with the latter serving as a “safe harbor” control [40], and cultured cells in a 1:1 ratio. The gene discussed is KDM5C; the disease is acute myeloid leukemia.